I am quite hopeful that post the release of the phase 1 results formally, this will pique big pharma interest in a formal way.
If the results are really as significant as we have so far been led to believe, there is probably a real chance that big pharma moves to acquire before the phase 2, with milestone payments.
Probably still unlikely but it's nice to dream.
FDA Application for Orphan Drug Designation , PAA, MPL, page-252
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.0¢ | $48.04K | 244.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 268036 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 38645 | 2 |
View Market Depth
| Last trade - 13.05pm 18/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |